Natco Lenalid 25mg |Lenalidomide tablet-uses,side effects,dose,price in India
LENALID 25MG
LENALID 25MG |
DESCRIPTION
Lenalid 25mg contains Lenalidomide as an active substance which belongs to thalidomide analogue. Lenalid 25mg contains some pharmacological activities like immuno modulatory, anti-neoplastic, & anti-angiogenesis. Lenalid 25mg is available in various strengths like 5mg, 10mg, 15mg & 25mg.Lenalid 25mg is a prescription medicine; used under the supervision of medical oncologist. Lenalid 25mg is used by combining with dexamethasone.
Indication
The most common indications of Lenalid 25mg are; Multiple myeloma: Lenalid 25mg should be used in combination with dexamethasone. Myelodysplastic syndrome: Lenalid 25mg is used to treat this condition Mantle cell lymphoma: Lenalid 25mg is used for this condition, if patients are not responding to the Bortezomib treatment.Mechansim
Lenalid 25mg tablet includes in the restraint of tumor rot factor alpha arrangement, which support the T-cells and causes lessening serum levels of cytokines vascular endothelial development factor and fundamental fibroblast development factor. Lenalid 25mg tablet is additionally engaged with the preclusion of angiogenesis. Lenalidomide is additionally empowered G1 cell cycle capture and apoptosis of ruinous cells.
Brand : Lenalid
Ingredients : Lenalidomide
Strength : 25mg Ingredients : Lenalidomide
Manufactured : Natco
Package : 30 TabletsDOSAGE MANAGEMENT
The usual prescribed dose of Lenalid in myelodysplastic syndromes is 10mg should be given as once a day. For renal damaged patients; In Patients with CrCl >60ml/min should not require dosage adjustment of Lenalid . In Patients with CrCl 30 to 60ml/min, 25mg of Lenalid should be given orally as once a day. In Patient with CrCl < 30ml/min, 2.25mg of Lenalid should be administered orally as a once a day. Dosage variation;THROMBOCYTOPENIA
Drops to <50000/mcL, therapy should be interrupted. Back to > or equal to 50000/mcL, continue the Lenalid of 25mg/day.NEUTROPENIA
Drops to <500/mcL, therapy should be postponed. Back to > or equal to 500/mcL, treatment should be continue to 25mg/day.MULTIPLE MYELOMA
In this condition, Lenalid is concomitant with dexamethasone. The usual dose of Lenalid is 225mg should be administered as once daily on day 1 to 21. The dose of dexamethasone; 40mg of dexamethasone should be followed on day 1 to 4, 9 to 12 & 17 to 20 of each 28 day cycles. Patient with >75 years, 20mg of dexamethasone should be recommended on day 1, 8, 15, & 22.MANTLE CELL LYMPHOMA
The advised dose of Lenalid 25mg tablet for this condition is 225mg should be administered orally as once daily. For renal damaged patients; Patient with CrCl 30 to 60ml/min, 10mg of Lenalid should be administered as once daily. Patient with CrCl < 30ml/min, 125mg of Lenalid should be used for q48hr. Pediatrics; The potency & effectiveness of Lenalidomide has not been evaluated in pediatric patients with age of <18 years.
For More Info :
Ph No : +91-9940472902Email : millionhealthpharmaceuticals@gmail.com
Website URL : https://millionpharma.com/lenalid-25mg.php
Comments
Post a Comment